These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 18583852)

  • 21. Hepatitis C Virus Sero-status in Hemodialysis Patients Returning from Holiday: Another Risk Factor for HCV Transmission.
    Al-Ghamdi SM; Al-Harbi AS
    Saudi J Kidney Dis Transpl; 2001; 12(1):14-20. PubMed ID: 18209355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of hepatitis B, hepatitis delta, and human immunodeficiency virus infections in Omani patients with renal diseases.
    Aghanashinikar PN; al-Dhahry SH; al-Marhuby HA; Buhl MR; Daar AS; Al-Hasani MK
    Transplant Proc; 1992 Oct; 24(5):1913-4. PubMed ID: 1412910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis C virus infection in patients on maintenance dialysis in kuwait: epidemiological profile and efficacy of prophylaxis.
    El-Reshaid K; Kapoor M; Sugathan T; Al-Mufti S; Al-Hilali N
    Saudi J Kidney Dis Transpl; 1995; 6(2):144-50. PubMed ID: 18583854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High Prevalence of Hepatitis C Virus Infection in Chronic Hemodialysis Patients.
    Carvalho M; Branco PB; Luvizotto ML; Valderrama DE; Rabone S; Doi E; Ivantes C; Muzzillo DA
    Braz J Infect Dis; 1999 Aug; 3(4):144-148. PubMed ID: 11096433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Seroprevalence of hepatitis C virus and hepatitis B virus among dialysis patients in Bahrain and Saudi Arabia.
    Almawi WY; Qadi AA; Tamim H; Ameen G; Bu-Ali A; Arrayid S; Abou Jaoude MM
    Transplant Proc; 2004; 36(6):1824-6. PubMed ID: 15350487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of chronic viral hepatitis on graft survival in Saudi renal transplant patients.
    Mitwalli AH; Alam A; Al-Wakeel J; Al Suwaida K; Tarif N; Schaar TA; Al Adbha B; Hammad D
    Nephron Clin Pract; 2006; 102(2):c72-80. PubMed ID: 16244496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Late seroconversion of C virus markers in hemodialysis patients.
    Oliva JA; Maymo RM; Carrio J; Delgado O; Mallafre JM
    Kidney Int Suppl; 1993 Jun; 41():S153-6. PubMed ID: 7686592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of hepatitis C infection and its risk factors in hemodialysis patients in tehran: preliminary report from "the effect of dialysis unit isolation on the incidence of hepatitis C in dialysis patients" project.
    Broumand B; Shamshirsaz AA; Kamgar M; Hashemi R; Aiazi F; Bekheirnia M; Boozary N; Komeilian Z; Shamshirsaz AH; Tabatabaiee MR; Broumand V
    Saudi J Kidney Dis Transpl; 2002; 13(4):467-72. PubMed ID: 17660669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis.
    Esteban JI; González A; Hernández JM; Viladomiu L; Sánchez C; López-Talavera JC; Lucea D; Martin-Vega C; Vidal X; Esteban R
    N Engl J Med; 1990 Oct; 323(16):1107-12. PubMed ID: 2170839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis C virus infection among dialysis patients in United arab emirates.
    El Shahat YI; Varma S; Bari MZ; Shah Nawaz M; Abdulrahman S; Pingle A
    Saudi J Kidney Dis Transpl; 1995; 6(2):157-62. PubMed ID: 18583857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Major risk of blood transfusion in hemolytic anemia patients.
    Omar N; Salama K; Adolf S; El-Saeed GS; Abdel Ghaffar N; Ezzat N
    Blood Coagul Fibrinolysis; 2011 Jun; 22(4):280-4. PubMed ID: 21508832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Investigation of hemodialysis patients in terms of the presence of occult hepatitis B].
    Altindiş M; Uslan I; Cetinkaya Z; Yüksel S; Ciftçi IH; Demirtürk N; Ozdemir M; Arslan F; Aktepe OC
    Mikrobiyol Bul; 2007 Apr; 41(2):227-33. PubMed ID: 17682709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of hepatitis C virus infection among hemodialysis patients in a single center in Yemen.
    Selm SB
    Saudi J Kidney Dis Transpl; 2010 Nov; 21(6):1165-8. PubMed ID: 21060200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of antibodies to hepatitis C virus in patients on peritoneal dialysis--a multicenter study.
    Gladziwa U; Schlipköter U; Lorbeer B; Cholmakow K; Roggendorf M; Sieberth HG
    Clin Nephrol; 1993 Jul; 40(1):46-52. PubMed ID: 7689431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy.
    Guadagnino V; Stroffolini T; Rapicetta M; Costantino A; Kondili LA; Menniti-Ippolito F; Caroleo B; Costa C; Griffo G; Loiacono L; Pisani V; Focà A; Piazza M
    Hepatology; 1997 Oct; 26(4):1006-11. PubMed ID: 9328327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
    Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H
    Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors associated to the prevalence of antibodies to hepatitis C virus among patients receiving hemodialysis at selected dialysis centers in Puerto Rico, 2005.
    Soto-Salgado M; Pérez CM; Burgos-Calderón R; Torres EA; Suárez E
    P R Health Sci J; 2009 Mar; 28(1):18-23. PubMed ID: 19266735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-ENA antibody profile in hepatitis C patients undergoing hemodialysis.
    Batchoun RG; Al-Najdawi MA; Al-Taamary S
    Saudi J Kidney Dis Transpl; 2011 Jul; 22(4):682-8. PubMed ID: 21743211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The prevalence of serum anti-hepatitis C virus antibodies in hemodialyzed patients].
    Motta M; Brischetto R; Rapisarda F; Corno C; Rapisarda C; Fatuzzo P; Messina A; Biondi A; Mezzasalma E; Calcara G
    Ann Ital Med Int; 1991; 6(4):375-8. PubMed ID: 1666516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.